Figure 2From: Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experienceSagittal MR images of the right breast of a patient with a complete pathologic response: (a) images prior to therapy and (b) at day 85. For each set, (i) is a T2-weighted image, (ii) is a contrast-enhanced image from a SPGR sequence, and (iii) is a subtraction image between (ii) and a pre-contrast baseline, respectively. MR, magnetic resonance; SPGR, spoiled gradient recalled.Back to article page